Skip to main content
. Author manuscript; available in PMC: 2018 Jul 6.
Published in final edited form as: Arch Phys Med Rehabil. 2017 Feb 1;98(5):971–980. doi: 10.1016/j.apmr.2016.12.023

Table 3.

Age, functional status, and discharge setting for cancer patients in IRFs (UDSMR), October 2010–September 2012 (N=27,952)

Cancer Type n % Age (y) Admission FIM Total Discharge FIM Total FIM Gain Discharge to Community

n %
All sites 27,952 100.0 65.1±14.1 61.2±16.4 84.7±22.1 23.5±16.2 20,195 72.2
Oral cavity and pharynx 293 1.0 68.6±11.9 59.8±16.1 90.2±19.6 30.4±15.5 223 76.1
 Tongue 74 0.3 66.5±12.2 61.9±17.6 92.7±21.3 30.7±16.0 55 74.3
 Mouth 76 0.3 67.9±11.4 58.7±14.1 91.2±19.4 32.5±14.3 58 76.3
 Pharynx 81 0.3 68.0±12.5 60.2±16.9 88.1±19.6 27.9±15.5 62 76.5
 Other oral cavity 62 0.2 72.8±10.6 57.9±15.5 88.5±17.5 30.7±16.3 48 77.4
Digestive system 3,346 12.0 74.3±10.6 62.8±15.2 89.7±19.4 26.9±16.0 2,465 73.7
 Esophagus 261 0.9 69.4±9.8 61.9±15.0 88.1±20.4 26.1±16.0 177 67.8
 Stomach 206 0.7 73.4±10.9 64.2±15.9 90.0±20.7 25.8±17.1 148 71.8
 Small intestine 74 0.3 73.3±10.2 63.9±15.0 89.8±23.4 25.8±18.5 52 70.3
 Colon 1,449 5.2 77.6±9.6 62.5±15.5 90.4±19.1 27.9±15.3 1,125 77.6
 Rectum 283 1.0 71.9±11.5 60.8±13.3 89.8±18.5 29.1±16.4 198 70.0
 Anus, anal canal, and anorectum 230 0.8 73.3±11.4 61.6±15.1 89.6±20.6 28.0±17.0 171 74.3
 Liver and intrahepatic bile duct 263 0.9 68.6±11.1 64.3±14.7 87.6±20.2 23.4±16.6 179 68.1
 Gallbladder and other biliary 72 0.3 74.2±9.8 63.9±17.1 86.6±18.8 22.8±16.2 46 63.9
 Pancreas 350 1.3 73.6±8.6 65.1±14.9 89.8±18.0 24.7±16.3 250 71.4
 Other digestive organs 158 0.6 70.9±10.8 61.1±14.8 89.8±19.5 28.8±15.3 119 75.3
Respiratory system 1,991 7.1 71.8±9.7 66.4±14.9 91.5±20.0 25.1±15.9 1,497 75.2
 Larynx 148 0.5 69.3±9.5 61.6±16.3 90.2±20.0 28.6±15.5 101 68.2
 Lung and bronchi 1,756 6.3 72.3±9.4 67.0±14.6 91.8±19.9 24.8±15.9 1,335 76.0
 Other respiratory organs 87 0.3 66.4±13.3 62.9±16.7 88.0±21.9 25.1±16.4 61 70.1
Bones and joints 2,437 8.7 62.1±14.7 64.7±14.4 86.7±20.5 22.2±15.8 712 70.8
Soft tissue 490 1.8 61.0±16.6 68.8±14.7 93.7±17.8 25.0±14.2 384 78.4
Skin 184 0.7 73.3±13.1 62.7±15.5 89.7±20.3 27.0±14.4 138 75.0
 Melanoma 76 0.3 71.3±14.0 65.4±15.1 93.0±18.5 27.7±13.7 56 73.7
 Other nonepithelial skin 108 0.4 74.7±12.3 60.9±15.6 87.4±21.3 26.5±14.9 82 75.9
Breast 283 1.0 69.3±13.0 63.6±15.5 90.0±20.0 26.4±16.5 216 76.3
Genital system 680 2.4 72.5±11.1 62.6±14.2 88.8±19.4 26.2±16.1 493 72.5
 Uterine cervix 37 0.1 63.5±14.1 64.9±11.4 89.0±17.6 24.1±16.0 26 70.3
 Uterine corpus 172 0.6 71.5±10.7 63.2±13.7 89.2±19.1 26.0±16.0 124 72.1
 Ovary 234 0.8 72.9±10.1 65.2±13.3 92.4±18.3 27.2±15.7 178 76.1
 Vulva 23 0.1 76.9±9.9 62.7±12.7 94.2±15.3 31.4±13.8 16 69.6
 Vagina and other genital, female 18 0.1 68.3±11.1 61.6±18.6 79.1±24.6 17.5±14.4 8 44.4
 Prostate 172 0.6 75.0±10.6 58.7±15.0 84.9±20.4 26.3±17.3 128 74.4
 Testis 1 0.0 29.0* 74.0* 104.0* 30.0* 1 100.0
 Penis and other genital, male 23 0.1 71.7±11.8 57.7±16.2 81.1±20.0 23.4±15.7 12 52.2
Urinary system 826 3.0 74.1±10.2 62.8±15.1 89.2±20.0 26.4±16.6 632 76.5
 Urinary bladder 366 1.3 75.6±9.7 59.2±14.6 86.1±20.6 26.9±17.5 269 73.5
 Kidney and renal pelvis 387 1.4 72.1±10.6 65.8±15.2 91.7±19.7 25.9±16.1 307 79.3
 Ureter and other urinary organs 73 0.3 76.8±9.1 64.4±13.0 91.3±16.8 26.9±15.0 55 76.7
Eye and orbit 9 0.0 72.8±16.1 70.6±11.1 97.2±14.0 26.7±10.7 9 100.0
Brain and other nervous system 14,780 52.9 61.4±13.7 58.9±17.1 81.2±23.1 22.3±16.3 10,721 72.5
Endocrine system 101 0.4 60.3±17.8 57.8±18.1 82.1±22.2 24.3±14.7 70 69.3
 Thyroid 24 0.1 69.8±12.3 67.1±13.7 91.3±21.3 24.2±13.4 16 66.7
 Other endocrine 77 0.3 57.4±18.3 54.9±18.4 79.3±21.9 24.3±15.2 54 70.1
Lymphoma 1,146 4.1 66.8±13.2 61.4±16.0 81.8±21.8 20.4±15.5 650 56.7
 Hodgkin lymphoma 43 0.2 57.9±21.0 64.8±15.9 84.0±21.7 19.2±17.7 29 67.4
 Non-Hodgkin lymphoma 1,103 3.9 67.1±12.7 61.3±16.0 81.7±21.8 20.4±15.5 621 56.3
Myeloma 580 2.1 66.5±11.6 64.7±14.1 86.4±19.9 21.6±14.6 397 68.4
Leukemia 402 1.4 63.4±16.8 65.6±15.4 89.9±20.0 24.3±16.1 273 67.9
 Acute lymphocytic leukemia 69 0.2 51.1±17.1 68.7±14.0 90.7±18.6 22.1±15.2 45 65.2
 Chronic lymphocytic leukemia 84 0.3 77.7±8.2 62.7±16.0 88.7±19.7 26.0±15.2 57 67.9
 Acute myeloid leukemia 170 0.6 60.4±15.3 66.6±15.1 91.6±19.2 25.0±15.9 120 70.6
 Chronic myeloid leukemia 33 0.1 65.6±13.6 65.6±14.9 88.4±22.9 22.8±19.8 23 69.7
 Other leukemia 46 0.2 65.7±16.7 62.2±16.9 85.4±23.3 23.2±17.0 28 60.9
Other and unspecified cancers 404 1.4 67.3±14.1 63.7±16.2 87.4±21.1 23.7±15.5 302 74.8

NOTE. Values are mean ± SD or as otherwise indicated.

*

No SD with value because only 1 case.